Form 4: Xencor Director Acquires Shares, Options Granted

Director Ellen Feigal acquired 10,302 shares of common stock and was granted options for 20,604 shares in a transaction on June 16, 2026.

Summary

• Director Ellen Feigal acquired 10,302 shares of Xencor Inc. common stock on June 16, 2026, at no cost.
• Following this acquisition, Feigal beneficially owns 22,642 shares of common stock.
• Additionally, Feigal was granted stock options to purchase 20,604 shares of common stock with an exercise price of $12.20.
• These options vest over one year, starting one month after June 16, 2026, with full vesting by June 16, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider activity related to compensation and ownership rather than a significant strategic event or financial performance indicator.

Positives

• Director Ellen Feigal has increased her direct beneficial ownership of Xencor Inc. common stock.
• The grant of stock options suggests a long-term incentive aligned with the company's performance.
• The vesting schedule for the options encourages continued commitment from the director.

Negatives

• The filing does not provide details on the reason for the acquisition of restricted stock units.
• The exercise price of the stock options ($12.20) is significantly higher than the current market price, implying a substantial increase in share value is needed for the options to be profitable.

Risks

• The value of the granted stock options is contingent on future stock price performance, which is subject to market volatility and company-specific risks.
• If the company's stock price does not appreciate sufficiently, the stock options may expire worthless.

Future Outlook

The vesting schedule for the stock options indicates a forward-looking expectation of continued company growth and stock price appreciation over the next year.

Industry Context

StockSavvy.ai notes that insider transactions, such as this Form 4 filing by a director, are common in the biotechnology and pharmaceutical sectors where stock-based compensation and ownership are used to align executive and director interests with shareholder value.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director may be viewed positively as a sign of confidence in the company's future. The stock options, if exercised, could lead to dilution if new shares are issued, but also indicate management's focus on long-term value creation.
• Employees: The stock option grant structure may influence employee morale and retention if similar incentives are offered.
• Management: The transaction reflects standard compensation practices for directors.

Next Steps

• Vesting of stock options over the next year.
• Potential exercise of stock options if the stock price exceeds the exercise price.

Key Dates

Keywords

Xencor Inc, XNCR, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Beneficial Ownership, Director Transaction, SEC Filing